SDGR insider transaction filings
Schrodinger, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-17. Screen SDGR transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Jain Rachit — EVP & CFO | Sale (S): 875 @ $15.60 | EDGAR |
| 2026-06-29 | 4 | Friesner Richard — Director | Gift (G): 679,373 @ $0 · Gift (G): 679,373 @ $0 | EDGAR |
| 2026-06-23 | 4 | Friesner Richard — Director | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Kapeller-Libermann Rosana — Director | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Thornberry Nancy — Director | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Sender Gary — Director | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Chodakewitz Jeffrey — Director | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Lynton Michael — Director | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | van Kralingen Bridget A — Director | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | OBEROI ARUN — Director | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | GINSBERG GARY L — Director | Grant/award (A): 8,141 @ $0 · Grant/award (A): 13,313 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | Jain Rachit — EVP & CFO | Sale (S): 844 @ $12.75 | EDGAR |
| 2026-04-17 | 4 | Farid Ramy — President & CEO, Director | Option exercise (M): 43,000 @ $3.07 · Sale (S): 43,000 @ $12.33 · Option exercise (M): 43,000 @ $3.07 · Sale (S): 43,000 @ $12.21 · Option exercise (M): 74,527 @ $3.07 · Option exercise (M): 43,000 (derivative) @ $0 · +2 more | EDGAR |
| 2026-03-06 | 4 | Jain Rachit — EVP & CFO | Sale (S): 1,631 @ $12.90 | EDGAR |
| 2026-03-06 | 4 | Abel Robert Lorne — See Remarks | Sale (S): 1,300 @ $12.81 | EDGAR |
| 2026-03-06 | 4 | Herman Jenny — CAO | Sale (S): 775 @ $12.85 · Sale (S): 608 @ $12.84 | EDGAR |
| 2026-03-06 | 4 | Tran Yvonne — EVP, CLO & CPO | Sale (S): 1,094 @ $12.89 | EDGAR |
| 2026-03-06 | 4 | Lorton Kenneth Patrick — EVP, CTO & COO, Software | Sale (S): 1,222 @ $12.90 | EDGAR |
| 2026-03-06 | 4 | Farid Ramy — President & CEO, Director | Sale (S): 3,661 @ $12.91 | EDGAR |
| 2026-03-06 | 4 | Akinsanya Karen — See Remarks | Sale (S): 1,366 @ $12.90 | EDGAR |
| 2026-03-03 | 4 | Jain Rachit — EVP & CFO | Grant/award (A): 17,130 @ $0 · Grant/award (A): 34,250 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Aklian Mannix Vartan — See Remarks | Grant/award (A): 17,130 @ $0 · Grant/award (A): 34,250 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Friesner Richard — Director | Option exercise (M): 160,527 @ $3.07 · Option exercise (M): 160,527 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Abel Robert Lorne — See Remarks | Grant/award (A): 17,130 @ $0 · Grant/award (A): 20,682 @ $0 · Grant/award (A): 34,250 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Herman Jenny — CAO | Grant/award (A): 9,590 @ $0 · Grant/award (A): 8,220 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Tran Yvonne — EVP, CLO & CPO | Grant/award (A): 17,130 @ $0 · Grant/award (A): 13,788 @ $0 · Grant/award (A): 34,250 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Lorton Kenneth Patrick — EVP, CTO & COO, Software | Grant/award (A): 17,130 @ $0 · Grant/award (A): 20,682 @ $0 · Grant/award (A): 34,250 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Farid Ramy — President & CEO, Director | Grant/award (A): 56,250 @ $0 · Grant/award (A): 13,604 @ $0 · Grant/award (A): 48,259 @ $0 · Sale (S): 5,560 @ $11.90 · Grant/award (A): 112,500 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Akinsanya Karen — See Remarks | Grant/award (A): 24,250 @ $0 · Grant/award (A): 6,077 @ $0 · Grant/award (A): 27,576 @ $0 · Sale (S): 2,206 @ $11.99 · Grant/award (A): 48,500 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | Herman Jenny — CAO | Sale (S): 752 @ $13.79 | EDGAR |
| 2026-02-12 | 4 | Tran Yvonne — EVP, CLO & CPO | Sale (S): 776 @ $13.80 | EDGAR |
| 2026-02-12 | 4 | Lorton Kenneth Patrick — EVP, CTO & COO, Software | Sale (S): 925 @ $13.73 | EDGAR |
| 2026-02-11 | 4 | Abel Robert Lorne — See Remarks | Sale (S): 1,230 @ $13.51 | EDGAR |
| 2025-10-17 | 4 | Dugan Margaret — Chief Medical Officer | Sale (S): 1,395 @ $21.07 | EDGAR |
| 2025-06-20 | 4 | Chodakewitz Jeffrey — Director | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Sender Gary — Director | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Lynton Michael — Director | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | van Kralingen Bridget A — Director | Grant/award (A): 1,499 @ $0 · Grant/award (A): 2,335 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Thornberry Nancy — Director | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Kapeller-Libermann Rosana — Director | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Friesner Richard — Director | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | OBEROI ARUN — Director | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | GINSBERG GARY L — Director | Grant/award (A): 5,997 @ $0 · Grant/award (A): 9,341 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Aklian Mannix Vartan — See Remarks | Grant/award (A): 14,063 @ $0 · Grant/award (A): 84,375 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Jain Rachit — EVP & CFO | Grant/award (A): 9,375 @ $0 · Grant/award (A): 18,750 (derivative) @ $0 | EDGAR |
| 2025-04-15 | 4 | Akinsanya Karen — President of R&D, Therapeutics | Option exercise (M): 13,378 @ $3.22 · Option exercise (M): 3,345 @ $2.92 · Sale (S): 8,378 @ $25.11 · Sale (S): 5,000 @ $25.11 · Sale (S): 3,345 @ $25 · Option exercise (M): 13,378 (derivative) @ $0 · +1 more | EDGAR |
| 2025-03-10 | 4 | van Kralingen Bridget A — Director | Grant/award (A): 10,000 @ $0 · Grant/award (A): 17,050 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Herman Jenny — SVP & Controller | Sale (S): 666 @ $21.11 | EDGAR |
| 2025-03-04 | 4 | Porges Geoffrey Craig — EVP & CFO | Grant/award (A): 12,500 @ $0 · Grant/award (A): 14,850 @ $0 · Sale (S): 5,491 @ $21.76 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Akinsanya Karen — President of R&D, Therapeutics | Grant/award (A): 15,625 @ $0 · Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — Schrodinger, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-29 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-06-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SDGR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →